Drug name,NSC,NSC.CDB,MOA,Clinical status
Etoposide,141540,141540,TOP2,FDA approved
Bortezomib,681239,681239,26S proteasome,FDA approved
Cisplatin,119875,119875,DNA crosslinking,FDA approved
Docetaxel,628503,628503,microtubules,FDA approved
Pevonedistat,793435,761192,NEDD8-activating enzyme,Clinical trial